Analysis of regional differences in the phase 3 METEOR study of cabozantinib (cabo) versus everolimus (eve) in advanced renal cell carcinoma (RCC)
暂无分享，去创建一个
T. Powles | R. Motzer | T. Choueiri | J. McCaffrey | B. Escudier | G. Gravis | M. Retz | I. Durán | M. Rink | N. Tannir | U. Giorgi | J. Larkin | T. Csoszi | M. Staehler | C. Caserta | D. Clary | F. Rolland | E. Gonzalez | W. Berg | S. Cheporov | T. Csőszi